Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Genervon ALS drug shows encouraging results
Seeking Alpha
Monday, October 20, 2014 - 10:19am
tags:
Genevron, ALS, GM604
FDA Accepts for Review a Biologics License Application for Merck and Sanofi’s Investigational Pediatric Hexavalent Vaccine
Yahoo
Monday, October 20, 2014 - 10:10am
tags:
FDA, Sanofi Pasteur, pediatric hexavalent vaccine, Merck, vaccines, diphtheria, tetanus, pertussis, Hib, hepatitis B
Could Galena Biopharma, Inc. Be Running Out of Money?
Motley Fool
Monday, October 20, 2014 - 9:47am
tags:
Galena Biopharma
Takeda and Orexigen Announce Availability of CONTRAVE® (naltrexone HCI and bupropion HCI) Extended-Release Tablets
Yahoo
Monday, October 20, 2014 - 9:07am
tags:
Takeda, Orexigen, Contrave, obesity
Hemispherx Biopharma Prevails in Multi-Million Dollar Federal Lawsuit
Yahoo
Monday, October 20, 2014 - 8:44am
tags:
Hemispherx Biopharma
What Johnson & Johnson Can Tell Us about Gilead Sciences, inc. Stock
Motley Fool
Monday, October 20, 2014 - 8:30am
tags:
JNJ, Gilead Sciences, Olysio, hepatitis C, Sovaldi
Biogen Expected To Report Positive Q3 Earnings
Bidness Etc.
Monday, October 20, 2014 - 8:23am
tags:
Biogen Idec, earnings
Valeant reports better-than-expected profit, raises forecast
Yahoo/Reuters
Monday, October 20, 2014 - 8:22am
tags:
Valeant Pharmaceuticals, earnings
Lilly CEO Sees Light After a Difficult Year
WSJ Online
Monday, October 20, 2014 - 8:19am
tags:
Eli Lilly, John Lechleiter, Pharma CEOs
Sanofi, Regeneron start Phase 3 trial of dupilumab in eczema
Yahoo/Reuters
Monday, October 20, 2014 - 8:17am
tags:
Sanofi, Regeneron, dupilumab, eczema
Purdue Says Kentucky Suit Over OxyContin Could Be Painful
Bloomberg
Monday, October 20, 2014 - 8:15am
tags:
Purdue, oxycontin, Kentucky
A Promising Experimental Ebola Drug Goes Overlooked
Bloomberg/Businessweek
Monday, October 20, 2014 - 8:13am
tags:
ebola virus, Sarepta Therapeutics, AVI-7537
NewLink in $1 bln deal with Roche to develop cancer drug
Yahoo/Reuters
Monday, October 20, 2014 - 8:11am
tags:
NewLink Genetics, Roche, cancer immunotherapy
Pfizer/AZ chase may be off as pharma deals falter
CNBC
Monday, October 20, 2014 - 8:10am
tags:
Pfizer, AstraZeneca, M&A
This Drug Could Outsell Medical Marijuana
Motley Fool
Sunday, October 19, 2014 - 12:36pm
tags:
Gilead, Harvoni, Sovaldi, hepatitis C, Medical Marijuana
Shire may turn acquirer after AbbVie deal collapse
Seeking Alpha
Sunday, October 19, 2014 - 12:33pm
tags:
Shire, M&A, Cubist Pharma, NPS Pharmaceuticals
Latest Actos Bladder Cancer Trial Starts in West Virginia
Legal Examiner
Sunday, October 19, 2014 - 10:26am
tags:
Actos, Takeda, diabetes
Sexual Dysfunction Drugs For Women Are About Profit, Not Equality
Huffington Post
Sunday, October 19, 2014 - 10:23am
tags:
female sexual dysfunction
Better Late Than Never: CMS Improves The Doctor Payment Website
WSJ Pharmalot
Saturday, October 18, 2014 - 11:31am
tags:
CMS, Medicare, Medicaid, physician payments, Physician Payment Sunshine Act
MannKind: 5 Potential Technosphere Applications
Seeking Alpha
Saturday, October 18, 2014 - 10:49am
tags:
MannKind, Technosphere

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.